Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
152.43
-2.15 (-1.39%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ascendis Pharma Employees
Ascendis Pharma had 1,017 employees as of December 31, 2024. The number of employees increased by 138 or 15.70% compared to the previous year.
Employees
1,017
Change (1Y)
138
Growth (1Y)
15.70%
Revenue / Employee
$370,186
Profits / Employee
-$384,889
Market Cap
9.12B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,017 | 138 | 15.70% |
Dec 31, 2023 | 879 | 82 | 10.29% |
Dec 31, 2022 | 797 | 158 | 24.73% |
Dec 31, 2021 | 639 | 157 | 32.57% |
Dec 31, 2020 | 482 | 152 | 46.06% |
Dec 31, 2019 | 330 | 114 | 52.78% |
Dec 31, 2018 | 216 | 79 | 57.66% |
Dec 31, 2017 | 137 | 36 | 35.64% |
Dec 31, 2016 | 101 | 23 | 29.49% |
Dec 31, 2015 | 78 | 23 | 41.82% |
Dec 31, 2014 | 55 | 10 | 22.22% |
Dec 31, 2013 | 45 | 7 | 18.42% |
Dec 31, 2012 | 38 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ASND News
- 8 days ago - Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday? - Benzinga
- 9 days ago - Ascendis Pharma A/S (ASND) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Ascendis Pharma A/S Announces Share Repurchase Program & Net Settlement of Certain RSUs - GlobeNewsWire
- 9 days ago - Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 16 days ago - Ascendis Pharma to Report Full Year 2024 Financial Results and Provide Business Update on February 12, 2025 - GlobeNewsWire
- 24 days ago - Ascendis-Novo Weight Loss Deal Highlights Technology Platform, Signals Growth Potential (Rating Upgrade) - Seeking Alpha
- 24 days ago - Ascendis Pharma: Danish Blockbuster Hunter - Seeking Alpha
- 5 weeks ago - Ascendis Pharma Provides Business and Strategic Roadmap Update at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire